Published in Am J Cancer Res on March 15, 2015
Lower MGMT expression predicts better prognosis in proneural-like glioblastoma. Int J Clin Exp Med (2015) 0.77
Association between Dietary Vitamin A Intake and the Risk of Glioma: Evidence from a Meta-analysis. Nutrients (2015) 0.76
Aldehyde dehydrogenase 1 expression has prognostic significance in patients with glioma. Mol Clin Oncol (2017) 0.75
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 25.96
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12
Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res (2009) 6.43
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res (2009) 4.36
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol (2009) 3.55
Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood (2005) 3.51
Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One (2010) 3.38
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med (2008) 2.67
Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology (2009) 2.44
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res (2010) 2.39
ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients. Brain Pathol (2012) 2.14
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood (2005) 1.80
Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia (2007) 1.57
Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. Oncogene (2014) 1.19
Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact (2012) 1.10
A simplified approach for the molecular classification of glioblastomas. PLoS One (2012) 1.05
Connexin 43 reverses malignant phenotypes of glioma stem cells by modulating E-cadherin. Stem Cells (2012) 1.01
Downregulation of MSP58 inhibits growth of human colorectal cancer cells via regulation of the cyclin D1-cyclin-dependent kinase 4-p21 pathway. Cancer Sci (2009) 1.01
Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. J Neurosci Res (2008) 0.99
Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma. Neuro Oncol (2012) 0.98
Gene expression signature-based prognostic risk score in patients with glioblastoma. Cancer Sci (2013) 0.93
Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma. Clin Cancer Res (2012) 0.84
Identification and validation of a gene expression signature that predicts outcome in malignant glioma patients. Int J Oncol (2011) 0.81